Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors - Top-Institutions - MDSpire

Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors

  • By

  • Ruonan Tan

  • Lili Guo

  • Saitian Li

  • Weiran Huang

  • Hang Zhang

  • Tongtong Gu

  • Qian Ba

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Shanghai General Hospital
    Shanghai General Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Surgical Oncology

  • #2

    Huashan Hospital of Fudan University
    Huashan Hospital of Fudan University

    Shanghai, Shanghai

    Key Differentiators

    • Surgical Oncology

  • #3

    University of Florida
    University of Florida

    Gainesville, Florida

    Key Differentiators

    • Surgical Oncology

  • #4

    Shanghai Cancer Center
    Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Surgical Oncology

  • #5

    Cancer Hospital, Fudan University
    Cancer Hospital, Fudan University

    Shanghai, Shanghai

    Key Differentiators

    • Surgical Oncology

Original Source(s)

Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors

  • by Ruonan Tan, Lili Guo, Saitian Li, Weiran Huang, Hang Zhang, Tongtong Gu, Qian Ba

  • July 14, 2026

Related Content

Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report